Drug Shortage Report for ATROPINE SULFATE INJECTION
Report ID | 153608 |
Drug Identification Number | 02426277 |
Brand name | ATROPINE SULFATE INJECTION |
Common or Proper name | Atropine Sulfate |
Company Name | LABORATOIRE AGUETTANT |
Market Status | MARKETED |
Active Ingredient(s) | ATROPINE SULFATE |
Strength(s) | 1MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
Packaging size | 5 mL pre-filled syringe |
ATC code | A03BA |
ATC description | BELLADONNAAND DERIVATIVES, PLAIN |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2022-02-03 |
Actual start date | 2022-02-02 |
Estimated end date | 2022-03-27 |
Actual end date | 2022-03-17 |
Shortage status | Resolved |
Updated date | 2022-03-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1, RUE ALEXANDER FLEMING LYON, RHÔNE FRANCE 69007 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2022-03-18 | French | Compare |
v5 | 2022-03-18 | English | Compare |
v4 | 2022-02-04 | English | Compare |
v3 | 2022-01-26 | French | Compare |
v2 | 2022-01-26 | English | Compare |
v1 | 2022-01-26 | English | Compare |
Showing 1 to 6 of 6